Computer models could revolutionize drug development.
Agriculture: Proponents of genetically modified forests could seek the regulatory green light in four years.
Biotech: Microelectronic and communications firms turn to life sciences.
Sensors that monitor vital signs will turn our "sick-care" system into one that preserves wellness.
Isolation of key genes at the heart of Alzheimer's disease has set off a frenzied race to find a drug to stop this cruel affliction in its tracks.
Automated production of highly complex molecules could aid understanding of many major diseases.
Decoy compounds show promise for new drug therapy.